1. Whither Autoimmunity: The Lessons of Anti-CCP and B cell Depletion

   • Yehuda Shoenfeld
   • M. Eric Gershwin

   OriginalPaper 09 September 2007 Pages: 1 - 3

2. Antibodies to Citrullinated Vimentin are a Specific and Sensitive Marker for the Diagnosis of Rheumatoid Arthritis

   • Hannah Poulsom
   • Peter J. Charles

   OriginalPaper 25 September 2007 Pages: 4 - 10

   

3. Does the Presence of Anti-CCP Autoantibodies and Their Serum Levels Influence the Severity and Activity in Rheumatoid Arthritis Patients?

   • Nikolaos G. Papadopoulos
   • Georgios Z. Tsiaousis
   • Vassiliki K. Galanopoulou

   OriginalPaper 13 September 2007 Pages: 11 - 15

   

4. Diagnostic Accuracy of Immunoassays for the Detection of Antibodies to Citrullinated Proteins

   • Nicola Bizzaro
   • Marilina Tampoia

   OriginalPaper 19 September 2007 Pages: 16 - 20

5. Comparison of Three Anti-CCP Antibody Tests and Rheumatoid Factor in RA and Control Patients

   • Ma Lurdes Correia
   • Saudade Carvalho
   • Ma Henriqueta Pereira

   OriginalPaper 18 September 2007 Pages: 21 - 25

   

6. Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis: As Good as it Gets?

   • Zoltán Szekanecz
   • Lilla Soós
   • Gabriella Lakos

   OriginalPaper 21 September 2007 Pages: 26 - 31

7. Share Epitope, Citrullinated Cyclic Peptide Antibodies and Smoking in Brazilian Rheumatoid Arthritis Patients

   • Rene Donizeti Oliveira
   • Cristina Maria Junta
   • Paulo Louzada-Junior

   OriginalPaper 15 August 2007 Pages: 32 - 35

   

8. Anti-CCP2 Antibodies: An Overview and Perspective of the Diagnostic Abilities of this Serological Marker for Early Rheumatoid Arthritis

   • Walther J. van Venrooij
   • Albert J. W. Zendman

   OriginalPaper Open access 18 September 2007 Pages: 36 - 39

9. Prevalence of Autoantibodies to Cyclic Citrullinated Peptide in Patients with Rheumatic Diseases other than Rheumatoid Arthritis: A French Multicenter Study

   • Nicole Fabien
   • Nils-Olivier Olsson
   • Jean Sibilia

   OriginalPaper 05 February 2008 Pages: 40 - 44

   

10. The Role of Anti-Cyclic Cytrullinate Antibodies Testing in Rheumatoid Arthritis

    • Cristiano Alessandri
    • Roberta Priori
    • Guido Valesini

    OriginalPaper 14 September 2007 Pages: 45 - 49

11. B-Cell Depletion and Repopulation in Autoimmune Diseases

    • Jacques-Olivier Pers
    • Capucine Daridon
    • Pierre Youinou

    OriginalPaper 06 September 2007 Pages: 50 - 55

    

12. Rituximab in Treatment-Resistant Autoimmune Blistering Skin Disorders

    • Enno Schmidt
    • Eva-Bettina Bröcker
    • Matthias Goebeler

    OriginalPaper 04 September 2007 Pages: 56 - 64

    

13. Analysis of Wegener’s Granulomatosis Responses to Rituximab: Current Evidence and Therapeutic Prospects

    • Achille Aouba
    • Christian Pagnoux
    • Loïc Guillevin

    OriginalPaper 12 September 2007 Pages: 65 - 73

    

14. Rituximab: Beyond Simple B Cell Depletion

    • A. Kessel
    • I. Rosner
    • E. Toubi

    OriginalPaper 01 February 2008 Pages: 74 - 79

    

15. Combined Therapy with Rituximab Plus Cyclophosphamide/Vincristine/Prednisone for Sjogren’s Syndrome-Associated B-Cell Non-Hodgkin’s Lymphoma

    • J. Carbone
    • R. Perez-Fernandez
    • E. Fernandez-Cruz

    OriginalPaper 22 August 2007 Pages: 80 - 84

    

16. Hepatitis B Virus (HBV) and Autoimmune Disease

    • Ram Maya
    • M. Eric Gershwin
    • Yehuda Shoenfeld

    OriginalPaper 18 September 2007 Pages: 85 - 102

    

17. Rituximab Off Label Use for Difficult-To-Treat Auto-Immune Diseases: Reappraisal of Benefits and Risks

    • Laurent Sailler

    OriginalPaper 07 September 2007 Pages: 103 - 110

18. Rituximab as a Therapeutic Tool in Severe Mixed Cryoglobulinemia

    • Dario Roccatello
    • Simone Baldovino
    • Luigi M. Sena

    OriginalPaper 21 August 2007 Pages: 111 - 117

    

19. Rituximab Induces Distinct Intraorbital and Intrathyroidal Effects in One Patient Satisfactorily Treated for Graves’ Ophthalmopathy

    • P. Bonara
    • G. Vannucchi
    • M. Salvi

    OriginalPaper 18 September 2007 Pages: 118 - 123

    

20. Should Rituximab be Considered as the First-Choice Treatment for Severe Autoimmune Rheumatic Diseases?

    • Claudio Galarza
    • Diana Valencia
    • Juan-Manuel Anaya

    OriginalPaper 22 September 2007 Pages: 124 - 128